BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2937208)

  • 1. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal control of disseminated breast cancer].
    Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
    Sov Med; 1990; (6):94-7. PubMed ID: 2144368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
    Tominaga T
    Gan No Rinsho; 1983 May; 29(6):628-31. PubMed ID: 6308307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
    Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
    Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Breast cancer and hormone therapy].
    Izuo M
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2830-6. PubMed ID: 2959203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
    Possinger K; Wagner H; Langecker P; Schmid L; Willich S; Wilmanns W
    Fortschr Med; 1987 Jul; 105(22):421-4. PubMed ID: 2958397
    [No Abstract]   [Full Text] [Related]  

  • 13. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
    Petru E; Schmähl D
    Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of breast cancer with hormones and drugs.
    Lippman ME
    Hosp Pract (Off Ed); 1986 May; 21(5):119-27, 131. PubMed ID: 3009506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L; Durand M; Bonichon F; Chauvergne J
    Bull Cancer; 1986; 73(2):148-54. PubMed ID: 2942203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of hormonotherapy of metastatic cancer of the breast].
    Namer M
    Bull Cancer; 1989; 76(1):65-73. PubMed ID: 2713517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
    Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA
    Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
    Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone therapy of breast cancer-its role in the treatment of breast cancer].
    Koyama H; Shiba E
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1177-81. PubMed ID: 2932568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
    Brufman G
    Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.